Recursion Pharmaceuticals

3.67
开盘价
3.52
市值
2.21B+
最高价
3.70
最低价
3.45
收盘价
3.70
成交量
19.02M+
市盈率
-2.79
股息率
0.00%

Recursion Pharmaceuticals简介

递归制药公司是一家临床阶段的生物技术公司,它结合了自动化、人工智能、机器学习和体内验证能力来发现新药。其递归操作系统使先进的机器学习方法能够揭示候选药物、作用机制、新的化学物质和潜在的毒性,最终目标是破译生物学并推进从根本上改善人们生活的新疗法。该公司由布莱克·博格森、克里斯托弗·C·吉布森和院长Y·理想汽车于2013年11月5日创立,总部位于德克萨斯州盐湖城。

如何购买 Recursion Pharmaceuticals (RXRX)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 RXRX

购买 RXRX

通过 RockFlow App 或网页端搜索 RXRX,输入您想要投资的金额,然后点击确认即可完成交易。

logo

社交媒体

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.